<DOC>
	<DOCNO>NCT02761889</DOCNO>
	<brief_summary>The present study evaluate clinical outcome follow definitive ultra-high dose per fraction external beam radiation therapy deliver patient organ-confined adenocarcinoma prostate . Patients enrol study undergo image-guided , volumetric intensity-modulated arc radiotherapy ( IGRT-VMAT ) state-of-the-art treatment-planning quality assurance procedure emphasis normal tissue spar delivery accuracy via use device ensure stability beam location reproducibility . A rectal balloon air fill use prostate target immobilization anatomical reproducibility , urethral catheter load beacon transponder use ensure set-up reproducibility online target track . Previously untreated patient prostate cancer treat 45 Gy five fraction 9 Gy 5 consecutive day . Patients follow one month post-treatment every 3 month 12 month ( +/- 4 week ) every 6 month ( +/- 6 week ) thereafter . Acute late toxicity evaluation focus , though exclusively , urinary , rectal sexual function assess validate Expanded Prostate Cancer Index Composite ( EPIC ) , International prostate symptom score ( IPSS ) International index erectile function ( IIEF ) questionnaires . Serum Prostate Specific Antigen ( PSA ) value draw schedule clinical follow-up . Patients continuously monitor minimum 5 year .</brief_summary>
	<brief_title>Hypofractionated Image-Guided Radiotherapy ( IGRT ) With Organ Motion Mitigation Urethral Sparing Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>Signed study specific inform consent form ; Histologic confirmation adenocarcinoma prostate biopsy ; Previous hormonal therapy allow ( require ) ; No direct evidence regional distant metastasis appropriate stag study ; Age ≥ 40 ; Performance Status 02 ; American Urological Association ( AUA ) score must ≤ 20 ( alpha blocker allow ) ; Computerized Tomography ( CT ) Ultrasoundbased volume estimation prostate gland ≤ 150 gram . Metastatic disease prostate cancer image study MRI evidence radiographic T3 , T4 ; Previous pelvic radiotherapy ; Previous surgery prostate cancer ; Previous hormonal therapy give 6 month prior therapy ; History Crohn 's Disease Ulcerative Colitis ; Previous significant obstructive symptom ; Significant psychiatric illness ; Severe , active comorbidity define section 3 .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>